Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of NUBPL mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of NUBPL mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NUBPL mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of NUBPL protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NUBPL mRNA | decreases expression | 20064835 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUBPL mRNA | decreases expression | 20018196
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NUBPL mRNA | decreases expression | 20106945
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of NUBPL mRNA | decreases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.03 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.78 | 6695378 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.22 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.38 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.01 | 17474063 20146248 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.82 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.82 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.82 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.82 | 12907637 12619106 21507988 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.10 | 20419170 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.71 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
12.08 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.08 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.08 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.09 | 19486331 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.06 | 15894690 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.94 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.94 | 18551238 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.99 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.49 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.49 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
9.49 | 2444490 18071297 19923254 15619225 19164858 12153990 11287661 11739529 16393943 14550746 19370779 11743745 16177239 12540782 12705907 12392966 16081117 14725611 11421492 19420014 15968718 11461765 11834606 11529661 10915739 16781746 17562736 18713872 16109766 19416960 19085960 10774834 16485898 10663392 17906064 17522070 12958197 16227642 14986274 19739265 12594235 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
9.49 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.47 | 19426721 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.52 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.52 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.10 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.45 | 12639820 12168785 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.05 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.77 | 20471113 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.89 | 16870215 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.17 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.42 | 14714311 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.22 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.22 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.57 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.57 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.57 | 12371664 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.67 | 19014921 19460945 12587719 12969438 16610002 16611625 11587558 19784758 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.46 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.90 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.90 | 15890375 2125692 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.90 | 20195826 21137059 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.44 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.44 | 8603461 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.47 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.47 | 6695378 20464547 18816296 18520028 20064080 17053015 20869020 18569708 20135361 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.32 | 14737004 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.87 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
OMIM:252010 |
MITOCHONDRIAL COMPLEX I DEFICIENCY |
marker/mechanism |
|
| |
MESH:D028361 |
Mitochondrial Diseases |
marker/mechanism |
|
| 20818383 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.37 | 16381670 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.50 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.50 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.27 | 11141357 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 19348381 18481113 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.07 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.66 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.66 | 16049721 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.59 | 16870215 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.17 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.17 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.39 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.39 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.46 | 10029692 19755658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.74 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.74 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.74 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.14 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.14 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.24 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |